-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Mexico's Sheinbaum to boost reporting of sexual abuse after being groped
-
Zuckerbergs put AI at heart of pledge to cure diseases
-
Crypto giant Coinbase fined in Ireland for rule breaches
-
Lawson relieved as he reveals FIA support following Mexican near-miss
-
US set for travel chaos as flights cut due to govt shutdown
-
Sabalenka and Pegula book their spots in WTA Finals last four
-
'Our brother-in-law': Arab world embraces New York's new mayor
-
France boss Deschamps would prefer to 'avoid playing' on Paris attacks anniversary
-
Pegula sweeps past Paolini to reach WTA Finals last four
-
Bolivian ex-president Anez leaves prison after sentence annuled
-
Stocks slide as investors weigh data, interest rate cuts
-
UN says 2025 to be among top three warmest years on record
-
Fleetwood and Lowry lift each other into Abu Dhabi lead
-
Fleetwod and Lowry lift each other into Abu Dhabi lead
-
New Zealand make changes after Barrett brothers' injuries as Scotland drop Van der Merwe
-
Dallas Cowboys' Marshawn Kneeland dies at 24: franchise
-
Pegula dispatches Paolini to keep WTA Finals semis bid alive
-
Dutch giants Ajax sack coach John Heitinga
-
Kirchner on trial in Argentina's 'biggest ever' corruption case
-
Amorim urges Man Utd to 'focus on future' after Ronaldo criticism
-
US judge drops criminal charges against Boeing over 737 MAX 8 crashes
-
World must face 'moral failure' of missing 1.5C: UN chief to COP30
-
UK grandmother leaves Indonesia death row to return home
-
Garcia broken nose adds to Barca defensive worries
-
Tight UK security ahead of match against Israeli club
-
Ethiopia's Afar region says attacked by Tigray forces
-
Nancy Pelosi, Democratic giant, Trump foe, first woman House speaker, to retire
-
Israel strikes Hezbollah targets in Lebanon
-
Burger strikes as South Africa restrict Pakistan to 269-9 in second ODI
-
Stocks slip as investors weigh earnings, tariffs
-
Police say 19 held after raid at Swedish start-up Stegra to be deported
-
Kante returns as France seek to clinch World Cup berth
-
Marcus Smith starts at full-back as England ring changes for Fiji
-
Kolisi 100th Test 'no distraction' for Erasmus' South Africa
-
Teetering Belgian government given more time to agree budget
-
Merz backs EU plan to protect steel sector from Chinese imports
-
New Zealand make Scotland changes after Barrett brothers' injuries
-
'Roy of the Rovers story' -- Farrell handed Ireland debut for Japan Test
-
Stones backs Man City team-mate Foden to pose England dilemma for Tuchel
-
Djokovic to face Alcaraz in ATP Finals groups
-
Facing climate 'overshoot', world heads into risky territory
-
Springbok skipper Kolisi to play 100th Test against France
-
Typhoon Kalmaegi hits Vietnam after killing 140 in Philippines
-
Bank of England leaves rate unchanged before UK budget
-
Germany recall Sane, hand El Mala debut for World Cup qualifers
-
India thump Australia to take 2-1 lead in T20 series
-
Cameroon's Biya, world's oldest president, sworn in for 8th term
-
Flick holding firm on Barca high line despite defensive woes
-
Battered US businesses eye improved China trade at Shanghai expo
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
V.AbuAwwad--SF-PST